Author: Abhay Panchal

In a groundbreaking study, Microsoft’s new AI tool, the Medical AI Diagnostic Orchestrator (MAI-DxO), correctly diagnosed 85% of complex medical cases from The New England Journal of Medicine — four times better than human doctors, who scored just 20%. The AI also did so 20% more cost-effectively. Unlike previous static models, MAI-DxO mimics the way doctors iteratively gather data, order tests, and reason through diagnoses — even emulating real-world consultations through an “orchestrator” system of multiple AI models like GPT, Claude, and Gemini. The project was advised by Dr. Eric Topol, a renowned physician-scientist, who called the findings “startling,” particularly…

Read More

In a landmark decision on June 27, 2025, the U.S. Supreme Court upheld the authority of the U.S. Preventive Services Task Force (USPSTF), preserving Affordable Care Act (ACA) provisions that mandate no-cost access to preventive healthcare services. The ruling stems from the Kennedy v. Braidwood case and reaffirms that USPSTF recommendations — such as colorectal cancer and hepatitis C screenings — must remain accessible without cost-sharing for patients. The Court validated that USPSTF operates constitutionally under the Department of Health and Human Services (HHS), with oversight retained by the HHS Secretary. While this is a win for public health and…

Read More

At DDW 2025, I shared a message I’ve felt building for years: the disruption in GI isn’t just technological—it’s existential. We’re not waiting for change—we’re already in it. The wave isn’t coming—it’s overhead. Most won’t realize it until it’s too late. The biggest barrier facing our field isn’t a lack of innovation. It’s our emotional and economic tether to single-procedure revenue streams like colonoscopy. We have to ask ourselves: Are we building a future-ready model—or clinging to a disappearing one? Though we spoke of the future, the talk was really about the uncomfortable present—and the decisions we keep postponing.A heartfelt thank you to American Gastroenterological…

Read More

A new Wolters Kluwer report, based on a national survey of 312 healthcare professionals, reveals that 42% of clinicians now use generative AI weekly, with medical librarians leading adoption. Key goals include tackling staffing shortages (82%), improving admin efficiency (77%), and easing burnout (76%). However, a stark readiness gap persists—only 18% of organizations have formal GenAI policies, and just 20% require staff training. Risks like decision-making erosion, data privacy, and bias remain top concerns. As Holly Urban of Wolters Kluwer notes, “These tools aren’t set-it-and-forget-it”—robust governance and continuous monitoring are vital.

Read More

A new study published in Gastrointestinal Endoscopy introduces EndoZip, an automated, operator-independent robotic endoscopic suturing system developed by Nitinotes Ltd (Israel) for gastric volume reduction. In a multicenter trial involving 45 patients with obesity (BMI 30–40), the EndoZip procedure led to an average total body weight loss of 13.2% at 12 months. Notably, over 76% of participants lost at least 5% of their body weight, with significant improvements in metabolic markers and quality of life. The system achieved a 100% technical success rate with minimal serious adverse events (4.4%), suggesting it may overcome the steep learning curve of manual endoscopic…

Read More

AGA, along with the American Medical Association and nearly 100 national and state medical associations, wrote to the Secretary of Health and Human Services Robert F. Kennedy Jr. to express opposition and concern on his decision to remove the entirety of the Advisory Committee on Immunization Practices (ACIP) within the Centers for Disease Control and Prevention (CDC).

Read More

The ADA’s 85th Scientific Sessions, taking place June 20–24 in Chicago, promise to mark a turning point in diabetes and obesity care. With a slate of late-breaking data releases, the spotlight is firmly on next-generation weight-loss treatments and transformative technologies in type 1 diabetes (T1D) management. Obesity: From Weekly to Monthly Dosing, and Beyond A major focus is on evolving weight-loss therapies that push beyond traditional GLP-1 receptor agonists (RAs). Highlights include: CagriSema (Novo Nordisk): A novel dual-agonist therapy combining semaglutide with cagrilintide (amylin + calcitonin RA). This “multi-angle” approach could raise the ceiling on safe, effective weight loss. MariTide…

Read More

Updated quality indicators for endoscopic ultrasound, published by the American Society for Gastrointestinal Endoscopy and the American College of Gastroenterology, reflect profound innovations that have occurred in the field in recent years, particularly the rise of interventional and therapeutic EUS, which did not exist when the previous esophagogastroduodenoscopy quality indicators were published in 2015. Lead author Girish Mishra, MD, the gastroenterology and hepatology section chief at Wake Forest University School of Medicine, in Winston-Salem, N.C., told Gastroenterology & Endoscopy News that because the field of interventional EUS has emerged only within the last decade, the new quality indicators reflect the…

Read More

In a groundbreaking peer-reviewed study published in Cureus, gastroenterologist Dr. Adewale Ajumobi and co-author Akash Patel evaluated the reliability of ChatGPT-4 in offering pre-colonoscopy instructions. The research posed 25 patient-style questions to ChatGPT, covering bowel prep, medication adjustments, and dietary guidelines—critical areas where patient confusion often derails procedures. The results? ChatGPT-4’s responses aligned 100% with clinical guidelines from leading global medical societies, including ESGE, USMSTF, ACG-CAG, ASGE, ACC-AHA, and ADS. It consistently recommended appropriate timing, prep steps, and medication protocols, demonstrating its potential as a dependable digital educator for GI patients.

Read More